Addition of Subcutaneous Daratumumab to Pd Improves Clinical Benefit in RRMM.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 14
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2021 AND VI 35 AND IP 1
Results: 15
1
2
Axicabtagene Ciloleucel Demonstrates Improved ORR in Indolent Non-Hodgkin Lymphoma.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 16
- By:
- Publication type:
- Article
3
Targeting TIGIT: Strengthening the Immune Checkpoint Blockade.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 44
- Publication type:
- Article
4
Continuing Advancements in Breast Cancer Care: Unraveling the data from the 2020 San Antonio Breast Cancer Symposium.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 11, doi. 10.46883/onc.2021.3501.0011
- Publication type:
- Article
5
Encouraging Advances in Hematologic Malignancies.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 6
- By:
- Publication type:
- Article
6
Building on Telehealth's Momentum.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 43
- By:
- Publication type:
- Article
7
High-Dose Imetelstat Improves OS, Offers Clinical Benefit in High-Risk Myelofibrosis.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 20
- By:
- Publication type:
- Article
8
Patient-Reported Outcomes of Pain and Related Symptoms in Integrative Oncology Practice and Clinical Research: Evidence and Recommendations.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 35, doi. 10.46883/onc.2021.3501.0035
- By:
- Publication type:
- Article
9
Spectacular Progress in Lung Cancer Care: "What we're doing is actually making an impact.".
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 26, doi. 10.46883/onc.2021.3501.0026
- Publication type:
- Article
10
Selinexor Shows Clinical Benefit, Despite Age, in Relapsed/Refractory DLBCL.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 24
- By:
- Publication type:
- Article
11
Continued Ibrutinib Treatment vs Placebo: Similar 1-Year DFS in CLL/SLL.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 21
- By:
- Publication type:
- Article
12
Barriers to Pancreatic Cancer Clinical Trials Enrollment.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 8
- By:
- Publication type:
- Article
13
Looking Toward a Bright Future: 2020 ASH Virtual Meeting Delivers Promising Data.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 7, doi. 10.46883/onc.2021.3501.0007
- By:
- Publication type:
- Article
14
ENZALUTAMIDE TREATMENT LOWERED RISK OF DEATH FOR PATIENTS WITH NONMETASTATIC CRPC.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 10
- By:
- Publication type:
- Article
15
CORRECTIONS:.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 1, p. 4
- Publication type:
- Article